A comparison of the effect of cholinesterase inhibitors on end-plate current and on cholinesterase activity in frog muscle.
D000818:Animals; D001001:Anura; D002093:Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism*; D005990:Glycerol / Q000494:pharmacology; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009045:Motor Endplate / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000201:enzymology*; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010830:Physostigmine / Q000494:pharmacology; D011893:Rana esculenta
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D002093:Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; D010830:Physostigmine; D002802:Cholinesterases; D005990:Glycerol